C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.
about
Relevance of fecal calprotectin and lactoferrin in the post-operative management of inflammatory bowel diseasesDisease monitoring in inflammatory bowel diseaseValidation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug EffectsEvolving Concepts in Phases I and II Drug Development for Crohn's Disease.Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's diseaseRelationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score.Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres.Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease.Luminally expressed gastrointestinal biomarkers.Compliance with the faecal calprotectin test in patients with inflammatory bowel disease.Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease.Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide.What to Do When Biologic Agents Are Not Working in Inflammatory Bowel Disease Patients.Approach to the Patient with Mild Crohn's Disease: a 2016 Update.Fecal biomarkers in inflammatory bowel disease: how, when and why?Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease.Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission.Capsule endoscopy for the diagnosis and follow up of Crohn's disease: a comprehensive review of current status.Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis.Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases.The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease.Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UCEfficacy and safety of golimumab 52-week maintenance therapy in Japanese patients with moderate to severely active ulcerative colitis: a phase 3, double-blind, randomized, placebo-controlled study-(PURSUIT-J study).Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn's Disease: A Pilot Study.Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.Sepsis Markers Soluble IL-2 Receptor and Soluble CD14 Subtype as Potential Biomarkers for Complete Mucosal Healing in Patients With Inflammatory Bowel Disease.The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis.The Lewis score or the capsule endoscopy Crohn's disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn's disease?Accuracy of Faecal Immunochemical Test to Predict Endoscopic and Histological Healing in Ulcerative Colitis: A Prospective Study Based on Validated Histological Scores.Inflammation-driven malnutrition: a new screening tool predicts outcome in Crohn's disease.The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease.TNFAIP6 is a potential biomarker of disease activity in inflammatory bowel disease.Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
P2860
Q26750230-8FC0A97A-C8C0-4D21-9709-1A08C4F3AC50Q26777553-DF7EC703-29C6-40A2-8764-6D3D83583C2CQ28552013-A9649B16-5F7A-43D7-AFFA-F519C6D5FF6DQ30248641-89486660-4963-43E7-95A4-2104FF74F695Q33667766-C062EA4F-B3DE-4D66-ADF2-5E151111B320Q36889586-DCD2F139-C763-4D12-8A89-70DF8A498EEAQ37273489-6E9762C3-387E-4F03-9D78-085C46FFA53FQ37601498-5AC905A4-B89A-4C80-921F-B6F66CEBEC05Q38608941-64DA4967-1094-49E0-BB07-5917AD0E9D19Q38620906-3FC38864-31B4-4579-994F-0384E773C90FQ38636313-784E3A8A-A751-4F7E-96C4-1492D7E4B320Q38641380-F2221FAC-9DA5-4209-8C4C-D634E64122BBQ38673082-E30A12F1-13E7-4EAD-BDEC-0B64DBBE6ED5Q38742261-EB846DCB-7430-4B65-BDA0-62817DE6818FQ38782416-D6D5BA48-F8AD-461B-BADB-2BB273CB8542Q38849974-A17521C6-4C95-4C8D-8357-EEEC9B8502DDQ38905783-0C278665-E718-48D1-AA39-4C775C183EAFQ38918650-88CE2E84-6D2E-4005-A2AE-3D52AFF01189Q38950036-00E04310-8E5A-452B-9960-DD20183058E5Q38950426-28F0BB72-501C-4E2E-A65D-23C70BD66BF7Q38988993-0CA4CFB6-4D50-494B-9883-E933126E2D75Q38990506-230EA2A9-7A30-4531-BA08-D3AD1D43E5A3Q39153608-40FC9D47-AEEB-4A5C-9E1F-4D4A272E2BFEQ39179611-AC69587C-5D5F-44C3-8AB8-9E993F8223A9Q39421189-F602E601-CFF5-45E0-B119-24C46A359137Q39825139-E637B902-5063-4C75-9681-E8F4DFA7F323Q40536632-22CC4555-2006-433A-BCFA-0E3196C91469Q40739614-47085477-7762-4A0D-A6B9-F9B90CE1F860Q42022217-EF07790B-1C1D-4653-9994-DFC60E28533FQ46934021-2381AA85-41F9-49A2-BBE1-5F6B192789DEQ47156789-36AA6A18-D5F6-493E-AFC3-5FF52025D9ABQ47588260-9D9F8D95-201B-43BC-B02C-F19352CE6018Q47725600-A8D3F1C4-BD05-442F-B528-2C0E322B28A0Q47964151-D0221C84-4C10-4B2C-A1FC-F6D4583C2D6EQ48109444-F24CFF65-27C9-43F7-9C3D-CEF9E7017887Q50205262-B01963E1-5953-44FC-BFAC-915A73377E4DQ51558934-DEBB88DA-73B3-4C0F-886F-A3FA1D838E71Q52676637-9FD02276-518A-47CD-BADE-0028D7588464Q53120172-4D15B49D-A317-4F86-9C0D-5DFA2D01AEA5Q53208202-4F44220D-DC09-4E18-85F4-69B86E2F8CE7
P2860
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
C-Reactive Protein, Fecal Calp ...... atic Review and Meta-Analysis.
@en
type
label
C-Reactive Protein, Fecal Calp ...... atic Review and Meta-Analysis.
@en
prefLabel
C-Reactive Protein, Fecal Calp ...... atic Review and Meta-Analysis.
@en
P2093
P2860
P50
P356
P1476
C-Reactive Protein, Fecal Calp ...... atic Review and Meta-Analysis.
@en
P2093
Guangyong Zou
John K MacDonald
Nilesh Chande
Sean G Feagan
Sushil K Garg
P2860
P304
802-19; quiz 820
P356
10.1038/AJG.2015.120
P407
P577
2015-05-12T00:00:00Z